Premium
Monitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology
Author(s) -
Annett Robert D.,
Patel Sunita K.,
Phipps Sean
Publication year - 2015
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.25749
Subject(s) - neuropsychology , medicine , neuropsychological assessment , pediatric oncology , psychological intervention , population , blood cancer , medline , pediatric cancer , pediatrics , oncology , clinical psychology , psychiatry , cancer , cognition , environmental health , political science , law
Central nervous system cancers or exposure to CNS‐directed therapies increase risk for neuropsychological deficits. There are no accepted guidelines for assessment of neuropsychological functioning in this population. A multifaceted literature search was conducted and relevant literature reviewed to inform the guidelines. Studies of neuropsychological outcomes are widely documented in the pediatric oncology literature. There is strong evidence of need for neuropsychological assessment, but insufficient evidence to guide the timing of assessment, nor to recommend specific interventions. Children with brain tumors and others at high risk for neuropsychological deficits should be monitored and assessed for neuropsychological deficits. Pediatr Blood Cancer 2015;9999:1–52. © 2015 Wiley Periodicals, Inc.